Literature DB >> 22552733

Progesterone levels on the hCG day and outcomes in vitro fertilization in women with polycystic ovary syndrome.

Cuiying Peng1, Zifen Guo, Xingyu Long, Guangxiu Lu.   

Abstract

BACKGROUND: The purpose of this study was to determine the incidence of premature luteinization in patients with polycystic ovary syndrome and compared the main determinants of success in in-vitro fertilization in PCOS patients with and without premature luteinization.
METHODS: Retrospective analysis of 180 PCOS women of Chinese Han origin with infertility who underwent controlled ovarian hyperstimulation (COH) with an exogenous gonadotropin/GnRH antagonist protocol. Hormone levels on the hCG day and IVF outcomes were assessed.
RESULTS: The incidence of premature luteinization was 23.3 %. Compared with PCOS patients without premature luteinization, PCOS patients with premature luteinization(PL) had a higher number of oocytes retrieved (18.20 ± 6.6 vs 15.08 ± 7.3, p = 0.037) and a higher fertilization rate (72.9 ± 1.9 vs63.1 ± 2.3, p = 0.033), but clinical pregnancy rates were no statistical significance (53.3 vs 56.0, p = 0.836). Though the implantation rate was higher in no premature luteinization patients, but the difference was not statistically significant (37.7 vs 30.3, p = 0.115).
CONCLUSION: The PCOS patients with premature luteinization had a higher fertilization rate and high number of oocytes retrieved, and the similar implantation rate and clinical PRs as PCOS patients without premature luteinization.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22552733      PMCID: PMC3401251          DOI: 10.1007/s10815-012-9762-6

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  26 in total

1.  PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors.

Authors:  F J Broekmans; E A H Knauff; O Valkenburg; J S Laven; M J Eijkemans; B C J M Fauser
Journal:  BJOG       Date:  2006-10       Impact factor: 6.531

2.  Progesterone rise on the day of HCG administration (premature luteinization) in IVF: an overdue update.

Authors:  Aboubakr M Elnashar
Journal:  J Assist Reprod Genet       Date:  2010-02-23       Impact factor: 3.412

3.  Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

Authors:  D A Ehrmann; R B Barnes; R L Rosenfield; M K Cavaghan; J Imperial
Journal:  Diabetes Care       Date:  1999-01       Impact factor: 19.112

4.  The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria.

Authors:  Ferdous Mehrabian; Behnaz Khani; Roya Kelishadi; Elham Ghanbari
Journal:  Endokrynol Pol       Date:  2011       Impact factor: 1.582

5.  Precycle administration of GnRH antagonist and microdose HCG decreases clinical pregnancy rates without affecting embryo quality and blastulation.

Authors:  Orhan Bukulmez; Khurram S Rehman; Martin Langley; Bruce R Carr; Anna C Nackley; Kathleen M Doody; Kevin J Doody
Journal:  Reprod Biomed Online       Date:  2006-10       Impact factor: 3.828

6.  Insulin resistance, obesity, hypofibrinolysis, hyperandrogenism, and coronary heart disease risk factors in 25 pre-perimenarchal girls age < or =14 years, 13 with precocious puberty, 23 with a first-degree relative with polycystic ovary syndrome.

Authors:  Charles J Glueck; John A Morrison; Ping Wang
Journal:  J Pediatr Endocrinol Metab       Date:  2008-10       Impact factor: 1.634

7.  Serum progesterone concentration on day of HCG administration and IVF outcome.

Authors:  R Li; J Qiao; L Wang; X Zhen; Y Lu
Journal:  Reprod Biomed Online       Date:  2008-05       Impact factor: 3.828

Review 8.  Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus.

Authors:  Fernando Ovalle; Ricardo Azziz
Journal:  Fertil Steril       Date:  2002-06       Impact factor: 7.329

9.  Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer.

Authors:  Evangelos G Papanikolaou; Efstratios M Kolibianakis; Cristina Pozzobon; Parikshit Tank; Herman Tournaye; Claire Bourgain; Andre Van Steirteghem; Paul Devroey
Journal:  Fertil Steril       Date:  2007-06-06       Impact factor: 7.329

10.  Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.

Authors:  R S Legro; A R Kunselman; W C Dodson; A Dunaif
Journal:  J Clin Endocrinol Metab       Date:  1999-01       Impact factor: 5.958

View more
  2 in total

Review 1.  The curious case of premature luteinization.

Authors:  Apostolos Kaponis; Elpiniki Chronopoulou; George Decavalas
Journal:  J Assist Reprod Genet       Date:  2018-07-26       Impact factor: 3.412

2.  Pre-Ovulatory Hormones on Day of Human Chorionic Gonadotropin Trigger and Assisted Reproductive Technique Outcomes in Different Ovarian Response Groups.

Authors:  Subarna Mitra; Madhuri Patil; Milind Patil; Prasanta Kumar Nayak
Journal:  J Hum Reprod Sci       Date:  2021-12-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.